How much is Cedilla Therapeutics worth in 2026?

Cedilla Therapeutics has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Cedilla Therapeutics raised?

Cedilla Therapeutics has raised N/A in total funding across 1 funding rounds.

Cedilla Therapeutics

Drug Discovery

Cedilla Therapeutics valuation and funding history | Last updated: October 25, 2021 | 1 funding rounds

Current Valuation

N/A

As of October 25, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$82.6M

Last Funding

Oct 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 25, 2021	Early Stage VC (Series B)	$82.6M	N/A	-

Valuation Analysis

Current Valuation Metrics

Cedilla Therapeutics is currently valued at N/A as of October 25, 2021.

Track Cedilla Therapeutics Valuation Updates

Get notified when Cedilla Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Cedilla Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Cedilla Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Cedilla Therapeutics Worth in 2026?

Cedilla Therapeutics is a leading private company in the Drug Discovery sector. Track Cedilla Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Cedilla Therapeutics Valuation is Determined

Private company valuations like Cedilla Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.